Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
ICMR
Mixed Dose Of Covaxin, Covishield Generates Four Times More Antibodies, Says Study
PTI
Jan 4, 2022 11:51 AM +05:30 IST
Omicron Covid Variant: Two Omicron Covid Cases Detected In India, Both In Karnataka
Swarajya Staff
Dec 2, 2021 05:05 PM +05:30 IST
PM Modi Chairs Key Meeting On COVID-19 Situation, Directs Officials To Be Proactive Amid New COVID Strain 'Omicron'
Swarajya Staff
Nov 27, 2021 03:11 PM +05:30 IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
Swarajya Staff
Nov 23, 2021 10:53 AM +05:30 IST
How August Turned Out To Be A Major Inflection Point For India’s Vaccination Effort
Suraj S
Sep 1, 2021 05:23 PM +05:30 IST
Single-Dose Of Covaxin On Covid-Recovered People Gives Similar Response As Two Doses On Uninfected: ICMR Study
Swarajya Staff
Aug 29, 2021 03:09 PM +05:30 IST
India's Export Of Surplus COVID-19 Testing Kits Projected To Touch 62 Crore Units By September 2021: ICMR
Swarajya Staff
Aug 18, 2021 10:04 AM +05:30 IST
ICMR Survey Reveal Healthcare Workers In Bihar's Buxar Have 94.1 Per Cent Seropositivity
Bhaswati Guha Majumder
Jul 27, 2021 03:30 PM +05:30 IST
Over 60 Per Cent Indians Have Covid-19 Antibodies But 40 Crore Are Still Vulnerable: ICMR
Bhaswati Guha Majumder
Jul 21, 2021 02:11 PM +05:30 IST
Covid-19 Third Wave May Hit In August But Would Be Less Severe, Predicts ICMR Expert
Bhaswati Guha Majumder
Jul 16, 2021 05:34 PM +05:30 IST
Covaxin Has 93.4 Per Cent Efficacy Against Severe COVID-19 Cases, Overall Efficacy At 77.8 Per Cent: Bharat Biotech
Swarajya Staff
Jul 3, 2021 08:34 AM +05:30 IST
ICMR Tells GoM That Second Wave Of Covid-19 Is Not Yet Over
Bhaswati Guha Majumder
Jun 29, 2021 05:56 PM +05:30 IST
Potential Covid-19 Third Wave Unlikely To Be As Severe As Second Wave: ICMR-Imperial College Study
Swarajya Staff
Jun 26, 2021 12:45 PM +05:30 IST
Covaxin And Covishield Works Against Alpha, Beta, Gamma And Delta Variants Of Covid-19: ICMR
Swarajya Staff
Jun 26, 2021 11:14 AM +05:30 IST
No, Covaxin Does Not Contain Cow: Here's The Truth
Swarajya Staff
Jun 16, 2021 05:37 PM +05:30 IST
'Supply Of Covaxin At Rs 150 Per Dose Not Sustainable': Bharat Biotech Defends Higher Price Of Its Jab For Private Markets
Swarajya Staff
Jun 15, 2021 04:06 PM +05:30 IST
ICMR To Conduct National Level Serosurveys To Assess Spread Of COVID-19
Swarajya Staff
Jun 12, 2021 11:41 AM +05:30 IST
Meril Receives ICMR Approval For Covid-19 Self-Test Kit CoviFind, Priced At Rs 250
Bhaswati Guha Majumder
Jun 11, 2021 04:49 PM +05:30 IST
ICMR Approves Two Home-Based Rapid Antigen Test Kits For COVID-19 Testing
IANS
Jun 4, 2021 08:13 AM +05:30 IST
Reliance Submits Proposal For Use Of Niclosamide As Potential COVID-19 Drug
IANS
Jun 3, 2021 09:19 AM +05:30 IST
Load More